Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Other financing activities (as filed) (2020 - 2024)

Updated

Rallybio's Other financing activities (as filed) came in at -$268,000 for FY2024, compared with -$139,000 in FY2023.

Analysis

Rallybio (RLYB) Other financing activities (as filed) (2020 - 2024) Analysis & Trends

Going back to FY2020, Rallybio's Other financing activities (as filed) data covers 5 years.

  • The five-year range for annual Other financing activities (as filed) is -$3.23 million (FY2021) to -$139,000 (FY2023).
  • Per Business Quant, earlier years put Other financing activities (as filed) at -$139,000 in FY2023, -$693,000 in FY2022, -$3.23 million in FY2021 and -$319,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rallybio 84.05 Mn -201.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -11,000.00
Jun 30, 2024 -257,000.00
Dec 31, 2023 -1,000.00
Jun 30, 2023 1,000.00
Mar 31, 2023 -139,000.00
Dec 31, 2022 -593,000.00
Sep 30, 2022 -100,000.00
Dec 31, 2021 -1.62 Mn
Sep 30, 2021 -949,000.00
Dec 31, 2020 -10,000.00
Sep 30, 2020 -309,000.00
API Access

Rallybio Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RLYB&period=max&api_key=YOUR_API_KEY